0001213900-23-048193.txt : 20230612 0001213900-23-048193.hdr.sgml : 20230612 20230612164700 ACCESSION NUMBER: 0001213900-23-048193 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230608 FILED AS OF DATE: 20230612 DATE AS OF CHANGE: 20230612 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Phillips Andrew John CENTRAL INDEX KEY: 0001921956 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39630 FILM NUMBER: 231008771 MAIL ADDRESS: STREET 1: C/O CORMORANT ASSET MANAGEMENT, LLP STREET 2: 200 CLARENDON STREET, FL 52 CITY: BOSTON STATE: MA ZIP: 02116 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MoonLake Immunotherapeutics CENTRAL INDEX KEY: 0001821586 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: DORFSTRASSE 29 CITY: ZUG STATE: V8 ZIP: 6300 BUSINESS PHONE: 41 41 510 8022 MAIL ADDRESS: STREET 1: DORFSTRASSE 29 CITY: ZUG STATE: V8 ZIP: 6300 FORMER COMPANY: FORMER CONFORMED NAME: Helix Acquisition Corp DATE OF NAME CHANGE: 20200818 4 1 ownership.xml X0407 4 2023-06-08 0 0001821586 MoonLake Immunotherapeutics MLTX 0001921956 Phillips Andrew John C/O MOONLAKE IMMUNOTHERAPEUTICS DORFSTRASSE 29 ZUG V8 6300 SWITZERLAND 1 0 0 0 0 Option to Buy 29.18 2023-06-08 4 A 0 11297 0.00 A 2033-06-08 Class A ordinary shares, par value $0.0001 per share 11297 11297 D This option represents a right to purchase a total of 11,297 Class A Ordinary Shares of the Issuer, which will vest in full the earlier of (i) June 8, 2024 and (ii) the date of the Issuer's next annual general meeting of shareholders, subject to the Reporting Person's continued service to the Issuer. /s/ Matthias Bodenstedt, Attorney-in-fact for Andrew John Phillips 2023-06-12